• Peptide vaccine technology involves prolonged suppression due to the production of anti-endogenous target protein antibody
• Peptide vaccines consist of highly immunogenic helper T cell epitope (AJP001) and B cell epitope originated from target protein
• Sharing the usefulness of antibody-inducing peptides based on non-clinical and clinical trial data of developed compounds

NEW COMPANY